CanadaBis Capital Inc. (CANB.V)

CAD 0.09

(-5.56%)

Net Income Summary of CanadaBis Capital Inc.

  • CanadaBis Capital Inc.'s latest annual net income in 2023 was 4.44 Million CAD , up 630.6% from previous year.
  • CanadaBis Capital Inc.'s latest quarterly net income in 2024 Q3 was 109.82 Thousand CAD , down -0.07% from previous quarter.
  • CanadaBis Capital Inc. reported an annual net income of 608.33 Thousand CAD in 2022, up 122.73% from previous year.
  • CanadaBis Capital Inc. reported an annual net income of -2.67 Million CAD in 2021, up 50.33% from previous year.
  • CanadaBis Capital Inc. reported a quarterly net income of 707.11 Thousand CAD for 2024 Q1, down -43.43% from previous quarter.
  • CanadaBis Capital Inc. reported a quarterly net income of 109.9 Thousand CAD for 2024 Q2, down -84.46% from previous quarter.

Annual Net Income Chart of CanadaBis Capital Inc. (2023 - 2017)

Historical Annual Net Income of CanadaBis Capital Inc. (2023 - 2017)

Year Net Income Net Income Growth
2023 4.44 Million CAD 630.6%
2022 608.33 Thousand CAD 122.73%
2021 -2.67 Million CAD 50.33%
2020 -5.38 Million CAD 40.14%
2019 -9 Million CAD -6406.98%
2018 -138.35 Thousand CAD 14.86%
2017 -162.5 Thousand CAD 0.0%

Peer Net Income Comparison of CanadaBis Capital Inc.

Name Net Income Net Income Difference
Aequus Pharmaceuticals Inc. -2.96 Million CAD 249.913%
Decibel Cannabis Company Inc. -1.77 Million CAD 351.101%
Delivra Health Brands Inc. 876 Thousand CAD -407.362%
Entourage Health Corp. -46.16 Million CAD 109.627%
Lifeist Wellness Inc. -14.12 Million CAD 131.464%
Cannara Biotech Inc. 6.94 Million CAD 36.008%
Medicure Inc. -922 Thousand CAD 582.049%
PharmaCielo Ltd. -16.29 Million CAD 127.271%
Rubicon Organics Inc. -1.82 Million CAD 343.729%
BioSyent Inc. 6.46 Million CAD 31.201%
Voyageur Pharmaceuticals Ltd. -1.39 Million CAD 417.584%